Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman Sells 3,982 Shares

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 3,982 shares of the firm’s stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $26.61, for a total transaction of $105,961.02. Following the completion of the sale, the general counsel now owns 159,137 shares of the company’s stock, valued at $4,234,635.57. This trade represents a 2.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Phreesia Trading Up 5.3 %

Shares of NYSE:PHR opened at $28.42 on Thursday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.77. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $29.16. The company has a market cap of $1.65 billion, a P/E ratio of -19.33 and a beta of 0.94. The stock’s fifty day moving average price is $22.50 and its 200-day moving average price is $22.53.

Phreesia (NYSE:PHR) last posted its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.29) by $0.04. The business had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business’s revenue for the quarter was up 16.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.58) EPS. Sell-side analysts expect that Phreesia, Inc. will post -1.16 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. JMP Securities restated a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a research note on Tuesday, December 10th. Truist Financial raised their price objective on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and upped their target price for the stock from $24.00 to $32.00 in a research report on Wednesday. Robert W. Baird lowered their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday, December 11th. Finally, Needham & Company LLC restated a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a report on Tuesday, December 10th. Eleven analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $30.64.

Hedge Funds Weigh In On Phreesia

Several institutional investors have recently made changes to their positions in the business. Bank of New York Mellon Corp raised its position in Phreesia by 8.4% in the second quarter. Bank of New York Mellon Corp now owns 214,430 shares of the company’s stock worth $4,546,000 after acquiring an additional 16,614 shares during the period. Rhumbline Advisers increased its stake in shares of Phreesia by 1.0% in the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock worth $1,741,000 after purchasing an additional 853 shares in the last quarter. Hsbc Holdings PLC bought a new position in Phreesia in the 2nd quarter worth $301,000. Sei Investments Co. lifted its position in Phreesia by 135.3% during the second quarter. Sei Investments Co. now owns 165,327 shares of the company’s stock valued at $3,505,000 after purchasing an additional 95,058 shares in the last quarter. Finally, Ensign Peak Advisors Inc grew its holdings in Phreesia by 3.2% during the second quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock valued at $477,000 after purchasing an additional 700 shares during the period. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.